In our study, we showed the important role of NGAL as a new inflammatory biomarker, which, when measured simultaneously with other markers of inflammation (i.e., CRP, and IL-6), turned out to be helpful (apart from clinical examination and anamnestic data and those obtained from imaging studies) in the diagnosis of appendicitis. The gene discussed is LCN2; the disease is appendicitis.